Who Paid My Doc
Mk-7264
Drug Respiratory
General payments
$109,185
Research payments
$9,527,469
Through program year 2020, $109,185 in general payments and $9,527,469 in research payments were reported against Mk-7264 (Respiratory).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $36,819 | 36 |
| 2020 | Research | $2,695,484 | 1,042 |
| 2019 | General | $72,367 | 153 |
| 2019 | Research | $6,831,985 | 2,067 |
Breakdown
The top 5 of 14 recipients; each share is of general payments naming this product in 2020.
The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 11 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
189 general · 3,109 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.